CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 179 filers reported holding CRISPR THERAPEUTICS AG in Q2 2018. The put-call ratio across all filers is 3.04 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $200,000 | -4.8% | 3,204 | +15.8% | 0.02% | -4.8% |
| Q4 2021 | $210,000 | -9.9% | 2,767 | +92.7% | 0.02% | -22.2% |
| Q2 2021 | $233,000 | +4.0% | 1,436 | -21.8% | 0.03% | +8.0% |
| Q1 2021 | $224,000 | -29.3% | 1,837 | -11.8% | 0.02% | -34.2% |
| Q4 2020 | $317,000 | +28.9% | 2,082 | -62.0% | 0.04% | -9.5% |
| Q3 2018 | $246,000 | -4.7% | 5,485 | +26.9% | 0.04% | -31.1% |
| Q2 2018 | $258,000 | – | 4,323 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |